Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CryoPort Inc (CYRX)
NASDAQ:CYRX
Holding CYRX?
Track your performance easily
CYRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.32 - $20.11
Previous Close$7.86
Volume496.95K
Average Volume (3M)419.62K
Market Cap
$382.59M
Enterprise Value$343.29M
Total Cash (Recent Filing)$272.67M
Total Debt (Recent Filing)$233.37M
Price to Earnings (P/E)―
Beta1.97
Next Earnings
Mar 06, 2025EPS Estimate
-$0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.39
Shares Outstanding49,430,583
10 Day Avg. Volume505,135
30 Day Avg. Volume419,624
Standard Deviation0.21
R-Squared0.16
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)1.01
Price to Sales (P/S)1.69
Price to Cash Flow (P/CF)214.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.52
Enterprise Value/Gross Profit3.46
Enterprise Value/Ebitda-2.77
Forecast
1Y Price Target
$11.43Price Target Upside45.42% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
CryoPort News
PremiumCompany Announcements
Cryoport Reports Growth in Life Sciences Services
PremiumPre-Earnings
Is CYRX a Buy, Before Earnings?
Bulls Say, Bears Say
Bulls Say
Financial PerformanceManagement reiterated its expectations for reaching positive adjusted EBITDA on a quarterly basis sometime in 2025.
Growth PotentialThe company is expecting commercial therapies to drive growth in 2025 and beyond, helping offset any weak clinical trials backdrop.
Product InnovationThe HV3, CYRX's next-gen shipper product, is expected to drive higher pricing and margins.
Bears Say
Financial Performance3Q24 revenue missed consensus.
Market ConditionsThe 3Q print points to continued pressure from capital spending slowdown and sluggish clinical trial activity.
Product DemandSofter MVE freezer demand resulted in weaker Products performance.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CYRX FAQ
What was CryoPort Inc’s price range in the past 12 months?
CryoPort Inc lowest stock price was $5.32 and its highest was $20.11 in the past 12 months.
What is CryoPort Inc’s market cap?
Currently, no data Available
When is CryoPort Inc’s upcoming earnings report date?
CryoPort Inc’s upcoming earnings report date is Mar 06, 2025 which is in 74 days.
How were CryoPort Inc’s earnings last quarter?
CryoPort Inc released its earnings results on Nov 07, 2024. The company reported -$0.02 earnings per share for the quarter, beating the consensus estimate of -$0.309 by $0.289.
Is CryoPort Inc overvalued?
According to Wall Street analysts CryoPort Inc’s price is currently Undervalued.
Does CryoPort Inc pay dividends?
CryoPort Inc does not currently pay dividends.
What is CryoPort Inc’s EPS estimate?
CryoPort Inc’s EPS estimate is -$0.29.
How many shares outstanding does CryoPort Inc have?
CryoPort Inc has 49,430,584 shares outstanding.
What happened to CryoPort Inc’s price movement after its last earnings report?
CryoPort Inc reported an EPS of -$0.02 in its last earnings report, beating expectations of -$0.309. Following the earnings report the stock price went down -3.616%.
Which hedge fund is a major shareholder of CryoPort Inc?
Among the largest hedge funds holding CryoPort Inc’s share is Blackstone Inc.. It holds CryoPort Inc’s shares valued at 4M.
---
CryoPort Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$11.43 (45.42% Upside)
$11.43 (45.42% Upside)
Blogger Sentiment
Bearish
CYRX Sentiment 100%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Increased
By 62.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $16.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.9%
Last 30 Days ▼ 6.9%
Last 30 Days ▼ 6.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-49.77%
12-Months-Change
Fundamentals
Return on Equity
-33.15%
Trailing 12-Months
Asset Growth
-29.87%
Trailing 12-Months
Company Description
CryoPort Inc
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.
---
CYRX Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call revealed a balanced sentiment with growth in the Life Sciences Services segment and new contract acquisitions being offset by challenges in the MVE Products business and reduced biopharma funding. The company's cost reduction strategies and strong balance sheet provide a stable outlook despite current market challenges.Read More>---
CYRX Stock 12 Month Forecast
Average Price Target
$11.43
▲(45.42% Upside)
Technical Analysis
Best Analysts Covering CYRX
1 Year
1 Year Success Rate
9/12 ratings generated profit
1 Year Average Return
+45.27%
reiterated a buy rating last month
Copying Richard Baldry's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +45.27% per trade.
---